ClinicalTrials.Veeva

Menu

Development and Validation of a Questionnaire to Measure the Impact of SBS and Its Treatments on Patients' Lives (ARTEMIS_GC)

C

Central Hospital, Nancy, France

Status

Unknown

Conditions

SBS - Short Bowel Syndrome

Treatments

Other: Think aloud interviews
Other: Delphi Process
Other: Semi-directive interviews
Other: Exploratory interviews
Other: Psychometric validation

Study type

Observational

Funder types

Other

Identifiers

NCT04150302
2019-A02034-53

Details and patient eligibility

About

Today, patients express a very strong need to take into account the consequences of their disease and its treatments in their therapeutic follow-up. It is therefore essential to better understand the needs, expectations and values of patients with SBS in order to better understand the impact of the disease on their lives, and thus improve the conditions for medical, social, psychological and technical care. The clinical expertise of health professionals and meetings with patient associations demonstrate the major gap between the parameters taken into account by physician to evaluate the evolution of the SBS and the day-to-day experience of the disease perceived by the patient.

The objective of the ARTEMIS-GC study is to develop and validate an instrument to measure the impact of SBS and its treatments on daily life from the perspective of patients.

Enrollment

250 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with SBS defined by a hail length remaining in post-duodenal < 2 meters
  • Patients with intestinal insufficiency, i.e. chronic malabsorption requiring energetic and/or hydro-electrolytic intravenous support for more than 6 months
  • Patients with a period of at least 6 months after the establishment of the SBS
  • Patients who has already had a return home after the establishment of the SBS for a period of at least 3 months

Exclusion criteria

  • Patients with intestinal insufficiency but with a cause other than SBS
  • Lack of understanding of the study
  • Not speaking French

Trial contacts and locations

1

Loading...

Central trial contact

Laetitia Ricci, PhD; Francisca Joly, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems